Detalles de la búsqueda
1.
An iterative approach to developing a multifaceted implementation strategy for a complex eHealth intervention within clinical practice.
BMC Health Serv Res
; 23(1): 1455, 2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129824
2.
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Catheter Cardiovasc Interv
; 98(3): 503-510, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33029937
3.
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.
Lancet
; 392(10153): 1117-1126, 2018 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190206
4.
Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Catheter Cardiovasc Interv
; 94(3): 342-347, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565371
5.
Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Catheter Cardiovasc Interv
; 90(2): E31-E37, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28145609
6.
Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction.
JAMA Cardiol
; 8(11): 1013-1021, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703036
7.
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.
EuroIntervention
; 19(10): e844-e855, 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860860
8.
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.
BMJ Open
; 11(7): e048994, 2021 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34233996
9.
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Cardiovasc Revasc Med
; 21(5): 567-570, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31662276
10.
2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
JACC Cardiovasc Interv
; 12(17): 1679-1687, 2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129092
11.
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
Int J Cardiol
; 226: 60-64, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27788391
12.
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry.
Open Heart
; 4(2): e000634, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28761685
13.
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
JACC Cardiovasc Interv
; 9(11): 1127-34, 2016 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27209254
14.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.
EuroIntervention
; 15(7): 603-606, 2019 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31147304
Resultados
1 -
14
de 14
1
Próxima >
>>